Studies on quinones. Part 42: Synthesis of furylquinone and hydroquinones with antiproliferative activity against human tumor cell lines

被引：32

作者：

Benites, Julio ^{[2
]}

Valderrama, Jaime A. ^{[1
]}

Rivera, Felipe ^{[1
]}

Rojo, Leonel ^{[2
]}

Campos, Nair ^{[3
]}

Pedro, Madalena ^{[3
]}

Jose Nascimento, Maria Saeo ^{[4
]}

机构：

[1] Pontificia Univ Catolica Chile, Fac Quim, Santiago, Chile

[2] Univ Arturo Prat, Dept Ciencias Quim & Farmaceut, Iquique, Chile

[3] Univ Porto, Fac Farm, Ctr Estudos Quim Organ Fitoquim & Farmacol, P-4100 Porto, Portugal

[4] Univ Porto, Fac Farm, Microbiol Lab, P-4100 Porto, Portugal

来源：

BIOORGANIC & MEDICINAL CHEMISTRY | 2008年 / 16卷 / 02期

关键词：

quinones; Michael addition; oxidative coupling; cytotoxicity;

D O I：

10.1016/j.bmc.2007.10.028

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

The preparation of furyl-1,4-quinone and hydroquinones by reaction of 2-furaldehyde N,N-dimethylhydrazone with benzo- and naphthoquinones is reported. Access to furylnaphthoquinones from unactivated quinones requires acid-induced conditions, however oxidative coupling reactions of activated quinones proceed under neutral conditions. The in vitro cytotoxic activity of the prepared compounds against a panel of three human cancer cell lines has been studied. Most of the furyl-1,4-quinones exhibited good antiproliferative activity (GI(50) = 6.5-33.5 mu m) against the MCF-7, NCI-H460, and SF-268 (CNS cancer) cell lines chosen for testing. (C) 2007 Elsevier Ltd. All rights reserved.

引用

页码：862 / 868

页数：7

共 50 条

[41] New Sorafenib Derivatives: Synthesis, Antiproliferative Activity Against Tumour Cell Lines and Antimetabolic Evaluation
Babic, Zeljka
Crkvencic, Maja
Rajic, Zrinka
Mikecin, Ana-Matea
Kralj, Marijeta
Balzarini, Jan
Petrova, Mariya
Vanderleyden, Jos
Zorc, Branka
MOLECULES, 2012, 17 (01): : 1124 - 1137
[42] Synthesis and Antiproliferative Activity of Coumarin-Estrogen Conjugates against Breast Cancer Cell Lines
Musa, Musiliyu A.
Khan, M. Omar F.
Cooperwood, John S.
LETTERS IN DRUG DESIGN & DISCOVERY, 2009, 6 (02) : 133 - 138
[43] HUMAN INTERFERON (IN) AND ALPHA-DIFLUOROMETHYLORNITHINE (DFMO) HAVE SYNERGISTIC ANTIPROLIFERATIVE ACTIVITY AGAINST HUMAN-TUMOR CELL-LINES INVITRO
KOVACH, JS
SVINGEN, PA
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1984, 25 (MAR): : 326 - 326
[44] Antiproliferative Activity of Polygonaceae Species from the Carpathian Basin against Human Cancer Cell Lines
Lajter, Ildiko
Zupko, Istvan
Molnar, Judit
Jakab, Gusztav
Balogh, Lajos
Vasas, Andrea
Hohmann, Judit
PHYTOTHERAPY RESEARCH, 2013, 27 (01) : 77 - 85
[45] ANTIPROLIFERATIVE ACTIVITY OF VINORELBINE (NAVELBINE) AGAINST 6 HUMAN-MELANOMA CELL-LINES
PHOTIOU, A
SHEIKH, MN
BAFALOUKOS, D
RETSAS, S
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1992, 118 (04) : 249 - 254
[46] Antiproliferative Activity of Some Higher Mushrooms from Hungary against Human Cancer Cell Lines
Vanyolos, Attila
Kovacs, Bernadett
Bozsity, Noemi
Zupko, Istvan
Hohmann, Judit
INTERNATIONAL JOURNAL OF MEDICINAL MUSHROOMS, 2015, 17 (12) : 1145 - 1149
[47] ANTIPROLIFERATIVE ACTIVITY OF TRAPA ACORNIS SHELL EXTRACTS AGAINST HUMAN BREAST CANCER CELL LINES
Pradhan, D.
Tripathy, G.
INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2014, 5 (06): : 2238 - 2243
[48] In vitro antiproliferative activity of a series of novel genistein glycoconjugates against human cancer cell lines
Gogler, A.
Rusin, A.
Glowala-Kosinska, M.
Kedzior, K.
Gruca, A.
Zawisza, J.
Szeja, W.
Grynkiewicz, G.
Krawczyk, Z.
FEBS JOURNAL, 2009, 276 : 311 - 311
[49] Antiproliferative activity of ent-abietane lactones against resistant human cancer cell lines
Duarte, N.
Loge, H.
Ferreira, M. J. U.
PLANTA MEDICA, 2008, 74 (09) : 984 - 985
[50] Semisynthetic derivatives of haemanthamine and their in vitro antiproliferative activity evaluation against a panel of human cell lines
Uher, Martin
Hroch, Milos
Perinova, Rozalie
Havelek, Radim
Kroustkova, Jana
Rezacova, Martina
Muthna, Darina
Koutova, Darja
Kunes, Jiri
Cahlikova, Lucie
ARABIAN JOURNAL OF CHEMISTRY, 2022, 15 (05)

← 1 2 3 4 5 →